The Use of Tocilizumab in Patients with COVID-19: A Systematic Review, Meta-Analysis and Trial Sequential Analysis of Randomized Controlled Studies

The Use of Tocilizumab in Patients with COVID-19: A Systematic Review, Meta-Analysis and Trial Sequential Analysis of Randomized Controlled Studies

Background: Among the several therapeutic options assessed for the treatment of coronavirus disease 2019 (COVID-19), tocilizumab (TCZ), an antagonist of the interleukine-6 receptor, has emerged as a promising therapeutic choice, especially for the severe form of the disease. Proper synthesis of the...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Alberto Enrico Maraolo, Anna Crispo, Michela Piezzo, Piergiacomo Di Gennaro, Maria Grazia Vitale, Domenico Mallardo, Luigi Ametrano, Egidio Celentano, Arturo Cuomo, Paolo A. Ascierto, Marco Cascella
Format: article
Langue:EN
Publié: MDPI AG 2021
Sujets:
COVID-19 pneumonia
tocilizumab
SARS-CoV-2
COVID-19
meta-analysis
trial sequential analysis
Medicine
R
Accès en ligne:https://doaj.org/article/40df4318293449579a3b4392e929bcbd
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Internet

https://doaj.org/article/40df4318293449579a3b4392e929bcbd

Documents similaires